Abstracts

Structural damage, particularly new bone formation (NBF) and progression thereof in the spine, is a well-recognised feature of axial…

Primary Budd-Chiari syndrome (BCS) is a rare hepatic vascular disorder characterised by hepatic venous outflow obstruction involving…

Alpha-1 antitrypsin deficiency-associated liver disease (AATD-LD) is characterised by the accumulation of misfolded alpha-1 antitrypsin…

Primary biliary cholangitis (PBC) management in Europe has undergone a significant transition following the European Medicines Agency’s…

Drug-induced liver injury (DILI) remains a major adverse drug reaction and a leading cause of drug development failure and post-marketing…

Immune checkpoint inhibitors (ICI) targeting programmed cell death-1 (PD-1) and programmed death ligand-1 (PD-L1) have transformed the…

Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognised as a systemic disorder driven by…

Sepsis in patients with cirrhosis carries an in-hospital mortality exceeding 40%, reflecting a pathophysiology distinct from sepsis in…